Osmolality, a measure of solute concentration, can have many applications throughout the entirety of the cell and gene therapy process. Low yield, the quality of product and the efficiency of the overall workflow are three current pain points for scientists within viral vector production and manufacturing. Increasing the manufacturing capacity, improving the production yields and the improvement of the supply chain logistics, can make these therapies accessible to larger patient populations, with a focus on a sustainable cost. So, what is the key to improvement in all areas? The answer being the implementation of a high-quality process design and the inclusion of process parameters to ensure robustness and reproducibility at all points within the workflow. In this webinar, the featured speaker will examine the use of osmolality within viral vector manufacturing.
Watch this webinar to take a look at the control of osmolality throughout the viral vector workflow and what this may mean for future process improvement within the field.
Kendal specializes in advancing novel osmolality applications within the biopharma industry. She is an experienced scientist with a demonstrated history of working in the biotechnology industry alongside sterilizing grade filters and pharmaceuticals. She graduated from the University of Portsmouth with Distinction in a research Masters’ degree looking at DNA extraction and amplification via PCR.
Please fill out the form to view this content.